The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Bristol-Myers Squibb; Merck Sharp & Dohme; Novartis
Lenvatinib plus pembrolizumab for patients with previously treated biliary tract cancers in the multicohort phase II LEAP-005 study.
 
Luis Villanueva
Research Funding - MSD
Travel, Accommodations, Expenses - Roche
 
Zarnie Lwin
Honoraria - AstraZeneca
Consulting or Advisory Role - Abbvie; AstraZeneca; Merck; Roche
Speakers' Bureau - AstraZeneca
Research Funding - Abbvie; Bristol-Myers Squibb
Travel, Accommodations, Expenses - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb
 
Hyun Cheol Chung
Consulting or Advisory Role - Amgen; Beigene; Bristol-Myers Squibb; Celltrion; Gloria Biosciences; Lilly; Merck Serono; MSD; Quintiles; Taiho Pharmaceutical; Zymeworks
Speakers' Bureau - Foundation medicine; Lilly; Merck Serono
Research Funding - Amgen; Beigene; Bristol-Myers Squibb; GlaxoSmithKline; Lilly; Merck Serono; MSD; Taiho Pharmaceutical
 
Carlos Gomez-Roca
Honoraria - AstraZeneca; Genentech/Roche; Pierre Fabre
Consulting or Advisory Role - Bristol-Myers Squibb; Erytech Pharma; Genentech/Roche; Novartis
Research Funding - Bristol-Myers Squibb/Roche (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Genentech/Roche; Pierre Fabre
 
Federico Longo
Honoraria - Amgen; Bayer; Bristol-Myers Squibb; Celgene; Ferrer; Lilly; Merck; MSD; Roche; Sanofi; SERVIER
Consulting or Advisory Role - Amgen; Bayer; Bristol-Myers Squibb; Lilly; MSD; Roche; SERVIER
Travel, Accommodations, Expenses - Amgen; Bayer; Bristol-Myers Squibb; Celgene; Ferrer; Lilly; Merck; MSD; Roche; Sanofi; SERVIER
 
Eduardo Yanez
Consulting or Advisory Role - Bristol-Myers Squibb; Merck Serono
Research Funding - Abbvie; Amgen; Astellas Pharma; Bristol-Myers Squibb; MSD; Pfizer; Roche
 
Helene Senellart
No Relationships to Disclose
 
Mark Doherty
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Eisai; Merck; Roche Canada
Research Funding - AstraZeneca; Merck
 
Javier García-Corbacho
Honoraria - Bayer
Travel, Accommodations, Expenses - Daiichi Sankyo; Novartis
 
Andrew Eugene Hendifar
Consulting or Advisory Role - Abbvie; Celgene; Ipsen; Novartis; Perthera
Research Funding - Ipsen
Travel, Accommodations, Expenses - Halozyme
 
Corinne Maurice-Dror
No Relationships to Disclose
 
Sanjeev Singh Gill
No Relationships to Disclose
 
Tae Won Kim
Employment - Asan Medical Center
Research Funding - AstraZeneca (Inst); Merck Serono (Inst); Sanofi (Inst)
 
Daniel Heudobler
Consulting or Advisory Role - Boehringer Ingelheim; Janssen-Cilag; MSD; Pfizer; Roche
Speakers' Bureau - Bristol-Myers Squibb; Novartis; Pfizer; Roche
Research Funding - Celgene (Inst)
Travel, Accommodations, Expenses - Boehringer Ingelheim; Celgene; Medac
 
Nicolas Penel
Research Funding - Bayer (Inst); Bayer (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; Astellas Pharma; Janssen-Cilag
Other Relationship - PharmaMar
 
Razi Ghori
Employment - Merck
 
Peter Kubiak
Employment - Eisai
 
Fan Jin
Employment - Merck
Stock and Other Ownership Interests - Merck
Travel, Accommodations, Expenses - Merck; Merck
 
Kevin Glen Norwood
Employment - Merck Sharp & Dohme
Stock and Other Ownership Interests - Merck
 
Donna Graham
Honoraria - Clinigen Group
Research Funding - Pfizer (Inst)